Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents

E-ISSN： 1875-5992|14|7|1042-1050

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.7, 2014-09, pp. : 1042-1050

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1558-1575

Bentham Science Publishers

Access to resources Recommend Favorite

Plant-Derived Protein Tyrosine Kinase Inhibitors as Anticancer Agents

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 4, Iss. 2, 2004-03 ,pp. : 173-197

Bentham Science Publishers

Access to resources Recommend Favorite

Protein Kinase CK2 Inhibitors: Emerging Anticancer Therapeutic Agents?

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 798-806

Bentham Science Publishers

Access to resources Recommend Favorite

ATP Non-Competitive Ser/Thr Kinase Inhibitors as Potential Anticancer Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 7, 2009-09 ,pp. : 778-786

Bentham Science Publishers

Access to resources Recommend Favorite

Aurora Kinase Family: A New Target for Anticancer Drug

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 2, 2008-01 ,pp. : 114-122

Bentham Science Publishers

Access to resources Recommend Favorite